Additionally, we have analyzed the response of MM cells with and without the deletion to bortezomib mediated killing and sensitization to TRAIL/APO2L triggered apoptosis in an attempt to understand why MM patients carrying 8p21 deletion respond poorly to bortezomib treatment. The gene discussed is TNFSF10; the disease is Miyoshi myopathy.